Digital Aria Co Ltd Net Assets
Digital Aria Co Ltd net assets. Based on the latest financial reports, Digital Aria Co Ltd (115450) has net assets worth ₩169.07 Billion KRW (≈ $114.58 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩220.71 Billion ≈ $149.57 Million USD) and total liabilities (₩51.64 Billion ≈ $35.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 115450 net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩169.07 Billion |
| % of Total Assets | 76.6% |
| Annual Growth Rate | 17.41% |
| 5-Year Change | 46.5% |
| 10-Year Change | 413.19% |
| Growth Volatility | 38.17 |
Net Assets of Digital Aria Co Ltd (2011–2025)
Net assets of Digital Aria Co Ltd from 2011 to 2025. This chart illustrates how Digital Aria Co Ltd's net assets have evolved over time, based on quarterly financial data. See 115450 equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Digital Aria Co Ltd (2011–2025)
The table below shows the annual net assets of Digital Aria Co Ltd from 2011 to 2025. For live market cap and overall valuation, see 115450 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩173.86 Billion ≈ $117.82 Million |
+10.41% |
| 2024-12-31 | ₩157.46 Billion ≈ $106.71 Million |
-8.19% |
| 2023-12-31 | ₩171.52 Billion ≈ $116.24 Million |
+46.96% |
| 2022-12-31 | ₩116.71 Billion ≈ $79.09 Million |
-1.66% |
| 2021-12-31 | ₩118.68 Billion ≈ $80.43 Million |
+32.82% |
| 2020-12-31 | ₩89.35 Billion ≈ $60.55 Million |
+39.75% |
| 2019-12-31 | ₩63.94 Billion ≈ $43.33 Million |
-6.89% |
| 2018-12-31 | ₩68.66 Billion ≈ $46.53 Million |
+78.61% |
| 2017-12-31 | ₩38.44 Billion ≈ $26.05 Million |
+13.47% |
| 2016-12-31 | ₩33.88 Billion ≈ $22.96 Million |
+12.62% |
| 2015-12-31 | ₩30.08 Billion ≈ $20.39 Million |
+33.60% |
| 2014-12-31 | ₩22.52 Billion ≈ $15.26 Million |
+116.95% |
| 2013-12-31 | ₩10.38 Billion ≈ $7.03 Million |
-26.33% |
| 2012-12-31 | ₩14.09 Billion ≈ $9.55 Million |
-23.35% |
| 2011-12-31 | ₩18.38 Billion ≈ $12.46 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Digital Aria Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1059729341000.0% over the analyzed period, indicating profitable operations and earnings retention.
Digital Aria Co Ltd Net Assets Breakdown (December 2025)
Digital Aria Co Ltd net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩10.60 Billion | 7.05% |
| Other Components | ₩139.66 Billion | 92.95% |
| Total Equity | ₩150.25 Billion | 100.00% |
Digital Aria Co Ltd Competitors by Market Cap
The table below lists competitors of Digital Aria Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ilex Medical
TA:ILX
|
$141.61 Million |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
$141.63 Million |
|
TTK Healthcare Limited
NSE:TTKHLTCARE
|
$141.74 Million |
|
Warehouses Estates Belgium SCA
BR:WEB
|
$141.87 Million |
|
ABC Taiwan Electronics
TWO:3236
|
$141.59 Million |
|
HIM International Music
TWO:8446
|
$141.54 Million |
|
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK
|
$141.39 Million |
|
TIZIANA LIFE SCIENCES LTD
F:0RP
|
$141.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Digital Aria Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 157,464,523,720 to 150,253,579,570, a change of -7,210,944,150 (-4.6%).
- Net loss of 9,226,687,730 reduced equity.
- Share repurchases of 354,550,710 reduced equity.
- New share issuances of 40,230,000 increased equity.
- Other factors increased equity by 2,330,064,290.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-9.23 Billion | -6.14% |
| Share Repurchases | ₩354.55 Million | -0.24% |
| Share Issuances | ₩40.23 Million | +0.03% |
| Other Changes | ₩2.33 Billion | +1.55% |
| Total Change | ₩- | -4.58% |
Book Value vs Market Value Analysis
This analysis compares Digital Aria Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.39x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.49x to 1.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1587.90 | ₩2370.00 | x |
| 2017-12-31 | ₩1684.07 | ₩2370.00 | x |
| 2018-12-31 | ₩2839.43 | ₩2370.00 | x |
| 2019-12-31 | ₩2588.35 | ₩2370.00 | x |
| 2020-12-31 | ₩3354.02 | ₩2370.00 | x |
| 2021-12-31 | ₩1847.92 | ₩2370.00 | x |
| 2022-12-31 | ₩1842.27 | ₩2370.00 | x |
| 2023-12-31 | ₩2124.29 | ₩2370.00 | x |
| 2024-12-31 | ₩1880.38 | ₩2370.00 | x |
| 2025-12-31 | ₩1704.42 | ₩2370.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Digital Aria Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -6.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.26%
- • Asset Turnover: 0.30x
- • Equity Multiplier: 1.52x
- Recent ROE (-6.14%) is above the historical average (-11.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -7.22% | -9.13% | 0.30x | 2.63x | ₩-3.84 Billion |
| 2015 | -14.30% | -25.63% | 0.33x | 1.67x | ₩-7.31 Billion |
| 2016 | -15.35% | -29.36% | 0.34x | 1.52x | ₩-8.59 Billion |
| 2017 | -12.53% | -28.08% | 0.27x | 1.63x | ₩-8.66 Billion |
| 2018 | 6.66% | 10.50% | 0.40x | 1.57x | ₩-2.29 Billion |
| 2019 | -25.69% | -27.85% | 0.42x | 2.18x | ₩-22.82 Billion |
| 2020 | -18.92% | -39.37% | 0.35x | 1.36x | ₩-25.84 Billion |
| 2021 | -14.49% | -39.46% | 0.23x | 1.60x | ₩-29.07 Billion |
| 2022 | -9.73% | -23.59% | 0.26x | 1.61x | ₩-23.02 Billion |
| 2023 | -1.43% | -4.38% | 0.26x | 1.25x | ₩-18.35 Billion |
| 2024 | -14.47% | -41.49% | 0.25x | 1.40x | ₩-38.54 Billion |
| 2025 | -6.14% | -13.26% | 0.30x | 1.52x | ₩-24.25 Billion |
Industry Comparison
This section compares Digital Aria Co Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $417,529,273,243
- Average return on equity (ROE) among peers: -6.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Digital Aria Co Ltd (115450) | ₩169.07 Billion | -7.22% | 0.31x | $141.59 Million |
| ORIENTBIO Inc. (002630) | $97.94 Billion | -19.53% | 0.76x | $96.19 Million |
| Green Cross (005250) | $1.97 Trillion | 1.67% | 0.83x | $290.81 Million |
| Green Cross Holdings Preference Shares (005257) | $1.67 Trillion | 10.22% | 0.94x | $2.85 Million |
| Pharmicell (005690) | $86.44 Billion | 7.32% | 0.15x | $367.60 Million |
| GeneOne Life Science Inc (011000) | $111.49 Billion | -69.75% | 0.35x | $32.81 Million |
| HLB Co. Ltd (028300) | $88.75 Billion | -14.89% | 1.10x | $3.02 Billion |
| Mgenplus Co. Ltd. (032790) | $18.79 Billion | 0.00% | 1.65x | $19.98 Million |
| Daesung Microbiological Labs. Co. Ltd (036480) | $25.09 Billion | 18.13% | 0.29x | $13.93 Million |
| Seoulin Bioscience Co.Ltd (038070) | $45.30 Billion | 4.03% | 0.46x | $21.44 Million |
| Hyundai Bioscience Co. Ltd (048410) | $60.94 Billion | 0.00% | 2.69x | $356.42 Million |
About Digital Aria Co Ltd
HLB Therapeutics Co.,Ltd., a biotech company, develops pharmaceutical products in South Korea and internationally. It is developing GBT-201 using Thymosin beta for the treatment of ophthalmic diseases, such as dry eye syndrome and neurotrophic keratopathy; and OKN-007 for the treatment of glioblastoma brain tumor. It is also involved in the wholesale of vaccines, as well as manufactures electrica… Read more